# Completeness Review: AIBloodBankDonationCenter

- **Review date:** 2026-07-18
- **Assessment basis:** Static source and configuration inspection only. Dependencies were not installed, and no build, database migration, external integration, or runtime workflow was executed.

## Classification

**Prototype-demo**

## Verdict

The repository presents a broad blood-bank operations surface (60 source files and 17 route modules), but the static evidence is characteristic of a generated prototype. Pages and endpoints demonstrate concepts; they do not establish a verified execution path for manage donor eligibility, collection, testing, component inventory, compatibility, allocation, and recalls.

## Why it is not complete

- The implemented surface does not include evidence that the principal domain integrations and operational workflows have been exercised end to end.
- 1 file references model-provider or chat-completion behavior; these generic LLM paths are not a substitute for deterministic domain execution, grounding, or evaluation.
- 19 files contain mock, sample, placeholder, or random-data signals, leaving important outcomes disconnected from authoritative systems.
- No recognizable application test files were found in the inspected tree.
- No CI workflow was found to continuously verify builds, tests, migrations, or security checks.
- No environment example/template was found, so required configuration and secret boundaries are undocumented.

## Needed features

- 1. Implement a workflow to manage donor eligibility, collection, testing, component inventory, compatibility, allocation, and recalls.
- 2. Connect donor/clinical systems, lab analyzers, barcode/cold-chain devices, hospitals, and notifications; replace seed/demo records with durable, synchronized data and explicit failure handling.
- 3. Validate identity, compatibility, expiry, quarantine, traceability, and emergency allocation scenarios.
- 4. Enforce health privacy, dual verification, regulatory records, and fail-safe blocking rules.
- 5. Add contract, integration, authorization, migration, and end-to-end tests in CI, plus a documented non-destructive deployment/run path.

## Risks or launch blockers

- The root launcher can terminate unrelated processes occupying configured ports.
- The root launcher seeds, creates, migrates, or otherwise mutates database state during startup.
- The root launcher installs dependencies at run time, reducing reproducibility and expanding supply-chain risk.
- Ungrounded or malformed model output can become a domain action unless schemas, evidence, evaluations, and approval gates are added.

## Evidence inspected

- `backend/package.json` — declared scripts, runtime dependencies, and application boundaries.
- `frontend/package.json` — declared scripts, runtime dependencies, and application boundaries.
- `backend/server.js` — service composition, middleware, and registered routes.
- `backend/routes/ai.js` — implemented API surface and domain/AI request handling.
- `backend/routes/auth.js` — implemented API surface and domain/AI request handling.
- `backend/routes/bloodtyping.js` — implemented API surface and domain/AI request handling.

## Recommended next action

Treat this as a prototype: select one narrow blood-bank operations outcome, remove or quarantine generated gap routes, and implement that outcome end to end with real data, deterministic rules, and tests before adding features.

## Implementation progress

- **1 — Implemented as a fail-safe local boundary:** `backend/domain/bloodLifecycle.js`, `backend/routes/allocationWorkflows.js`, and `backend/migrations/001_governed_blood_lifecycle.sql` join recorded eligibility, identity, collection/testing evidence, component quarantine, expiry, cold chain, trace events, conservative exact-type matching, allocation, and two-person verification in one durable workflow. It does not authorize transfusion.
- **2 — Boundary implemented; external adapters blocked:** every business API is now authenticated, workflow writes are idempotent/tenant-scoped/audited, and provider/device state must be evidenced. Donor/clinical systems, analyzers, barcode/cold-chain devices, hospitals, and notification providers require real contracts, credentials, acknowledgements, reconciliation, and failure testing.
- **3 — Implemented locally and fails closed:** missing identity/eligibility/tests, reactive or incomplete tests, quarantine, expiry, temperature excursions, incomplete traceability, and any compatibility case beyond exact ABO/Rh are blocked. Emergency allocation and broader compatibility policies require licensed clinical validation and are intentionally not fabricated.
- **4 — Implemented locally:** self-registration cannot select a privileged role; qualified verifier roles and two distinct actors are required; tenant, optimistic-version, evidence-hash, and audit-event boundaries were added. Health-privacy deployment, retention, regulator records, and validated dual-control procedures remain external launch blockers.
- **5 and launch risks — Implemented locally:** tests, CI, `.env.example`, strict JWT/production database configuration, explicit migrations, non-destructive startup/bootstrap, and guarded destructive demo seeding were added. Static checks and two domain tests pass; dependencies, database, clinical systems, devices, and professional validation were not run.
